TRX585
TRX585 is a humanised anti-immunoglobulin-like transcript 5 (ILT5) monoclonal antibody. TRX585 has a potent immunoregulatory activity. TRX585 significantly activates human T cells and upregulates NKG2D and Fas ligand, followed by enhancing antitumor activity with potent cytotoxicity. TRX585 can be used for viral infections and malignancies research[1].
Product Specifications
UNSPSC
12352203
Target
C-type Lectin-like Receptors (CTLRs)
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Inflammation/Immunology
References & Citations
[1]Apostolou I, et al. Immunoregulatory properties of TRX585, a novel monoclonal antibody specific for immunoglobulin-like transcript 5[J]. Journal of Clinical Oncology, 2010, 28 (15_suppl) : e13107-e13107.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TP320075 20 µg
67kDa Laminin Receptor (RPSA) (NM_001012321) Human Recombinant Protein
Ask
View Details 
MBS520817-01 0.1 mg
Anti-Human Galectin-8, Affinity Purified, (Polyclonal), (Rabbit IgG)
Ask
View Details 
MBS520817-02 5x 0.1 mg
Anti-Human Galectin-8, Affinity Purified, (Polyclonal), (Rabbit IgG)
Ask
View Details 
039327-Biotin 200 µL
OR14J1, CT (OR14J1, OR5U1, Olfactory receptor 14J1, Hs6M1-28, Olfactory receptor 5U1, Olfactory receptor OR6-25) (Biotin) discontinued
Ask
View Details